Jane Street
IMMU

Jane Street’s Immunomedics Inc IMMU Stock Holding History

Jane Street’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-25,600
Closed -$2.18M – 8510
2020
Q3 		$2.18M Sell
25,600
-46,700
-65% -$2.36M ﹤0.01% 2902
2020
Q2 		$2.56M Buy
72,300
+13,200
+22% +$386K ﹤0.01% 2723
2020
Q1 		$796K Buy
59,100
+36,700
+164% +$618K ﹤0.01% 3061
2019
Q4 		$474K Buy
+22,400
New +$395K ﹤0.01% 3748
2019
Q1 		– Sell
-30,100
Closed -$430K – 5935
2018
Q4 		$430K Buy
30,100
+14,100
+88% +$280K ﹤0.01% 3628
2018
Q3 		$333K Sell
16,000
-1,100
-6% -$26.1K ﹤0.01% 4085
2018
Q2 		$405K Buy
+17,100
New +$344K ﹤0.01% 3820
2017
Q4 		– Sell
-15,700
Closed -$219K – 5412
2017
Q3 		$219K Buy
+15,700
New +$156K ﹤0.01% 4041

Jane Street's IMMU Position: Q4 2020 in Review

Jane Street sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 144,311 shares — an estimated $12.3M sold.

Jane Street first reported a position in IMMU in Q2 2013 and held it in 17 quarters. The position peaked at $15.9M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Jane Street reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Jane Street sold 144,311 Immunomedics Inc shares in Q4 2020, an estimated $12.3M.
  • Jane Street first reported a position in Immunomedics Inc in Q2 2013 and held it in 17 quarters.
  • Jane Street's Immunomedics Inc position peaked at $15.9M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Jane Street's 13F filing for Q4 2020, filed 17 Feb 2021.